Ever wish that you could make your dog's life longer? While crossing the rainbow bridge is part of a dog's short life, ...

Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for ...

The Food and Drug Administration (FDA) has approved Harliku ™ (nitisinone) for the reduction of urine homogentisic acid (HGA) in adult patients with alkaptonuria.

The approval was based on two phase 1 crossover studies, which compared zanubrutinib tablets with the capsule formulation in healthy adult participants.

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...

The US Food and Drug Administration (FDA) has granted approval to a tablet formulation of BeOne Medicines’ targeted cancer ...

FDA approves new Brukinsa tablet for five blood cancers, offering simpler dosing with the same safety and effectiveness as ...

While Botox was the first neuromodulator of its kind approved by the Food and Drug Administration (FDA) in 2009, ... Approved in 2024 for frown lines (aka 11 lines) ...

A drug commonly used in treatment for urinary tract infections may carry a risk of cancer, according to a recent study. The Independent reports that the study from the National Toxicology Program ...